Literature DB >> 9672944

Trends in tobacco smoking and consequences on health in France.

C Hill1.   

Abstract

OBJECTIVE: This paper describes the trends in tobacco sales and smoking prevalence in the French population, estimates the consequences of smoking on the mortality of this population, and discusses governmental actions: anti-tobacco campaigns, a ban on advertising, restriction of smoking in public places, and price increases. DATA SOURCES: Sales data were collected from the French tobacco monopoly, smoking prevalence data from surveys conducted by several institutes, and mortality statistics by cause from the Institut National de la Santé et de la Recherche Médicale.
RESULTS: Tobacco sales increased from 3 g per adult per day at the beginning of the century to a maximum of 6.8 g in 1975, then decreased by 10% between 1991 and 1996. Since the early 1950s, the proportion of smokers has been on the decline in the male population and on the increase in the female population. In France, 60,000 deaths are attributable to tobacco smoking. These deaths represent 12% of the total mortality. The advertising ban has been enforced and the recent price increase has led to a drop in sales.
CONCLUSIONS: The consequences of tobacco smoking on the health of the female French population will increase for another 30 years, because of the increase in female smoking observed in the recent past, whereas the epidemic is leveling off in the male population.

Entities:  

Mesh:

Year:  1998        PMID: 9672944     DOI: 10.1006/pmed.1998.0319

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

1.  A prospective investigation of the impact of smoking bans on tobacco cessation and relapse.

Authors:  D R Longo; J C Johnson; R L Kruse; R C Brownson; J E Hewett
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

2.  Dying for a smoke: how much does differential mortality of smokers affect estimated life-course smoking prevalence?

Authors:  Rebekka Christopoulou; Jeffrey Han; Ahmed Jaber; Dean R Lillard
Journal:  Prev Med       Date:  2010-11-20       Impact factor: 4.018

3.  Smoking behavior and opinions of French general practitioners.

Authors:  L Josseran; G King; A Velter; C Dressen; D Grizeau
Journal:  J Natl Med Assoc       Date:  2000-08       Impact factor: 1.798

4.  Incidence trends for potentially human papillomavirus-related and -unrelated head and neck cancers in France using population-based cancer registries data: 1980-2012.

Authors:  Karine Jéhannin-Ligier; Aurélien Belot; Anne-Valérie Guizard; Nadine Bossard; Guy Launoy; Zoé Uhry
Journal:  Int J Cancer       Date:  2017-02-22       Impact factor: 7.396

5.  Lung cancer attributable to indoor radon exposure in france: impact of the risk models and uncertainty analysis.

Authors:  Olivier Catelinois; Agnès Rogel; Dominique Laurier; Solenne Billon; Denis Hemon; Pierre Verger; Margot Tirmarche
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

6.  Non-small-cell lung cancer in a French department, (1982-1997): management and outcome.

Authors:  J Foeglé; G Hédelin; M P Lebitasy; A Purohit; M Velten; E Quoix
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

Review 7.  Attributable risk of lung cancer deaths due to indoor radon exposure.

Authors:  Si-Heon Kim; Won Ju Hwang; Jeong-Sook Cho; Dae Ryong Kang
Journal:  Ann Occup Environ Med       Date:  2016-02-26

8.  Impact of social inequalities at birth on the longevity of children born 1914-1916: A cohort study.

Authors:  Nicolas Todd; Sophie Le Fur; Pierre Bougnères; Alain-Jacques Valleron
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

9.  Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing.

Authors:  G Defossez; Z Uhry; P Delafosse; E Dantony; T d'Almeida; S Plouvier; N Bossard; A M Bouvier; F Molinié; A S Woronoff; M Colonna; P Grosclaude; L Remontet; A Monnereau
Journal:  BMC Cancer       Date:  2021-06-24       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.